Literature DB >> 6860432

Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis.

S Omura, N Sadakane, Y Tanaka, H Matsubara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860432     DOI: 10.7164/antibiotics.36.927

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Cloning of spiramycin biosynthetic genes and their use in constructing Streptomyces ambofaciens mutants defective in spiramycin biosynthesis.

Authors:  M A Richardson; S Kuhstoss; M L Huber; L Ford; O Godfrey; J R Turner; R N Rao
Journal:  J Bacteriol       Date:  1990-07       Impact factor: 3.490

Review 3.  Philosophy of new drug discovery.

Authors:  S Omura
Journal:  Microbiol Rev       Date:  1986-09

4.  Post-PKS tailoring steps of the spiramycin macrolactone ring in Streptomyces ambofaciens.

Authors:  Hoang-Chuong Nguyen; Emmanuelle Darbon; Robert Thai; Jean-Luc Pernodet; Sylvie Lautru
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

5.  Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain.

Authors:  S Omura; H Ikeda; F Malpartida; H M Kieser; D A Hopwood
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

6.  Combined chemical and biosynthetic route to access a new apoptolidin congener.

Authors:  Victor P Ghidu; Ioanna Ntai; Jingqi Wang; Aaron T Jacobs; Lawrence J Marnett; Brian O Bachmann; Gary A Sulikowski
Journal:  Org Lett       Date:  2009-07-16       Impact factor: 6.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.